Open AccessEstimation of salivary Candida albicans counts in asthmatic adult patients taking anti-asthmatic medication for 3–5 years
Author(s) -
Aruna Kumari,
Vikram S Amberkar,
Kirthi Kumar,
DB Nandini,
B Vidyasagar
Publication year - 2018
Publication title -
journal of oral and maxillofacial pathology/journal of oral and maxillofacial pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.455
H-Index - 25
eISSN - 1998-393X
pISSN - 0973-029X
DOI - 10.4103/jomfp.jomfp_36_17
Subject(s) - saliva , candida albicans , asthma , medicine , corpus albicans , immunology , microbiology and biotechnology , biology
Bronchial asthma is a chronic inflammatory disease of airways. The disease itself along with the principal medication used makes the oral cavity susceptible to most common opportunistic infection, i.e., oral candidiasis. There are many species of Candida causing oral candidiasis, but the most prevalent among them is Candida albicans . Hence, assessing C. albicans count in response to disease and its treatment is necessary. This enables us to educate asthma patients about side effects of medication and highlight the necessity for oral health care, thereby improving their quality of life.